Experimental therapy gantenerumab fails to slow or improve Alzheimer’s memory loss in clinical trials

Posted on March 21, 2024 by blkalertshealth

An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday.

Posted in HealthTagged Black Health, black people health, blacknews, CNN, nbcnews, newswirelink, TIME, us health

Previous: US gets D+ grade for rising preterm birth rates, new report finds

Next: Covid-19 boosters could keep thousands of kids out of hospitals, but uptake remains low

Health

CDC warns of increase in bacterial illnesses that can lead to meningitis and possibly death

blkalertshealth
March 30, 2024
0

The CDC issued an alert to doctors about an increa

Health

A Person in the U.S. Tested Positive for Bird Flu

blkalertshealth
April 2, 2024
0

Health

A Test Told Me I’m Basically Made of Plastic. You Probably Are Too

blkalertshealth
April 28, 2024
0

I might like to think of my body as a thing

New Comments

First Bullet Train Line Approved to Enter Service – BossFM Digital on First Bullet Train Line Approved to Enter Service
US Admitting Asylum Seekers, No Longer Enforcing “Remain in Mexico” Program – BossFM Digital on US Admitting Asylum Seekers, No Longer Enforcing “Remain in Mexico” Program
Moratorium Ending, Millions Face Eviction – BossFM Digital on Moratorium Ending, Millions Face Eviction
Journal of Neuroscience Study Finds Psychological Importance of Face-to-Face Interaction – BossFM Digital on Journal of Neuroscience Study Finds Psychological Importance of Face-to-Face Interaction

Related Posts

CDC warns of increase in bacterial illnesses that can lead to meningitis and possibly death

A Person in the U.S. Tested Positive for Bird Flu

A Test Told Me I’m Basically Made of Plastic. You Probably Are Too